Dapoxetine hydrochloride is a selective serotonin reuptake inhibitor and the first drug approved for the on-demand treatment of premature ejaculation (PE). Its safety was established in a thorough clinical development program.
Results from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: the PAUSE study / Mirone, Vincenzo; Arcaniolo, Davide; Rivas, David; Bull, Scott; Aquilina, Joseph W; Verze, Paolo; PAUSE study, Team; Balercia, Giancarlo. - In: EUROPEAN UROLOGY. - ISSN 1873-7560. - 65:4(2014), p. 733-9. [10.1016/j.eururo.2013.08.018]
Results from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: the PAUSE study
BALERCIA, GIANCARLO
2014-01-01
Abstract
Dapoxetine hydrochloride is a selective serotonin reuptake inhibitor and the first drug approved for the on-demand treatment of premature ejaculation (PE). Its safety was established in a thorough clinical development program.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
